ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0133

Activation of IL-17 Expressing Cells Following AKI Contributes to Sodium-Sensitive Hypertension, Development of Tertiary Lymphoid Structures, and Increased Angiotensin II (Ang II) Constriction

Session Information

  • AKI: Mechanisms - 3
    November 08, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Basile, David P., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Mehrotra, Purvi, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Ullah, Md Mahbub, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Collett, Jason Andrieu, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Lewis, Alexander, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Arêas, Guilherme Peixoto Tinoco, University of Illinois Chicago College of Applied Health Sciences, Chicago, Illinois, United States
  • Phillips, Shane, University of Illinois Chicago College of Applied Health Sciences, Chicago, Illinois, United States
Background

Following I/R induced AKI, rats develop salt-sensitive hypertension, CKD, and manifest enhanced vascular constriction sensitivity. Th17 (CD4+ IL17+) cells are induced following AKI and are restimulated by high salt diet. This study sought to determine the effects of IL17 on immune cell infiltration, hypertension and peripheral vascular reactivity post AKI.

Methods

Study I: Male Sprague-Dawley rats were subjected to unilateral I/R (40min) and allowed to recover for 5 weeks on low salt diet (0.4%). Following a right nephrectomy (UNX), rats were provided elevated dietary salt (4%) and treated with either anti-IL17 (α-IL17) or non-immune IgG for 4 additional weeks. Study II: Additional studies were performed in wild type (WT) rats or rats with impaired Th17 activation (i.e., Rorc-/- ) to investigate microvascular responses to ANG II stimulation 5 weeks following unilateral I/R.

Results

Renal hypertrophy was evident in post-AKI control IgG rats vs sham (~14%), and was significantly attenuated by αIL-17 (p<0.05). There was a significant increase in IL17+ cells, IFNγ+, total CD4 cells, CD8 cells, B-cells, neutrophils and dendritic/macrophages cells; all of which were attenuated by >50% in αIL-17 vs control IgG treated rats (p<0.05). Mean arterial pressure by telemetry was attenuated by α-IL17 treatment vs control IgG post I/R (131.0 ±1.2 vs 170.6± 11.6 mmHg; p<0.05). Histology showed substantial immune cell infiltration in post-AKI control rats, including apparent tertiary lymphoid structures (TLS), which were generally absent in αIL-17 treated rats (p<0.05). These structures contained loose aggregates of T and B cells and occasional evidence of B-geminal zones. In study II, alterations in vascular responses in isolated gracilis arterioles from WT rats 5 weeks post AKI showed enhanced pressor responses to ANG II versus sham. In contrast, this response was absent in vessels from Rorc-/- rats, which show impaired Th17 activity post-IR.

Conclusion

These data suggest that the Th17/IL17 pathway has substantial effects on the pathophysiology of AKI-to-CKD, by influencing inflammation and the formation of TLS, as well as blood pressure control and peripheral vascular responses.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)